초록 ▼

The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by exposure to aqueous streams. The present inven

The present invention provides water-soluble, extended-release chemical formulations, in tablet form, for urine pretreatment, that require minimal, if any, use of a binder component, yet are non-dusting, pliable, structurally strong, and not weakened by exposure to aqueous streams. The present invention also provides a simple and reliable method for controlled dispensing of such tableted formulations into a liquid stream that is particularly advantageous for use in micro-gravity environments, such as spacecraft urinal systems.

대표청구항 ▼

A method for controlled dispensing of a water soluble, extended-release chemical formulation into a liquid stream whereby said chemical formulation controls and prevents microbial growth and/or controls and prevents precipitation of solids in and transfer of odorous gases from urine, wherein said me

A method for controlled dispensing of a water soluble, extended-release chemical formulation into a liquid stream whereby said chemical formulation controls and prevents microbial growth and/or controls and prevents precipitation of solids in and transfer of odorous gases from urine, wherein said method comprises: securing an extended-release chemical formulation, in tablet form, within a permeable casing; and mounting said permeable casing, containing said tableted chemical formulation, in a liquid flow path leading to urine collection hardware or in said urine collection hardware, whereby, as liquid contacts said tableted chemical formulation secured within, said casing, said tableted formulation slowly dissolves into said liquid thereby controlling and preventing microbial growth and/or controlling and preventing precipitation of solids in and transfer of odorous gases from urine, wherein said chemical formulation comprises: a biocide; and/or an organic acid or an acid salt; and up to about 10% by weight of an extended-release binder, wherein said biocide is an acid oxidizing compound selected from the group including monopersulfate compounds, copper sulfate, silver nitrate, and mixtures thereof, wherein said organic acid is selected from the group including citric, oxalic, and maleic acids, and mixtures thereof, wherein said acid salt is selected from the group including potassium bisulfate, sodium bisulfate, cupric chloride, silver nitrate, and mixtures thereof; wherein said binder is comprised of: at least one polyol having an average molecular weight ranging from about 600 to about 20,000 grams/mole; and, up to about 5% weight, based on the total weight of said binder, of polyethylene oxide; and wherein, when said chemical formulation comprises an organic acid and an extended-release binder, said formulation is prepared by either a method comprising: preparing a mixture made up of said organic acid and said binder; heating said prepared mixture to a temperature of from about 45°C. to about 70°C.; cooling said heated mixture to ambient temperature; and pressing said cooled mixture into at least one tablet, or by a method comprising: heating said organic acid, alone or in combination with said binder, to a temperature sufficient to melt said acid to form a melt; optionally, adding said binder to said melt; pouring said melt into at least one mold; and cooling said melt, contained into said mold(s), to form at least one tablet.